Travere Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.7M | 412k | 8.99 |
| 2023-09-30 | $2.9M | 329k | 8.94 |
| 2023-06-30 | $3.5M | 229k | 15.36 |
| 2023-03-31 | $2.8M | 126k | 22.49 |
| 2022-12-31 | $4.4M | 210k | 21.03 |
| 2022-09-30 | $1.0M | 42k | 24.00 |
| 2022-06-30 | $2.4M | 102k | 24.00 |
| 2022-03-31 | $4.0M | 153k | 26.00 |
| 2021-12-31 | $5.1M | 164k | 31.02 |
| 2021-09-30 | $14k | 599 | 24.00 |
| 2021-06-30 | $214k | 14k | 14.93 |
| 2021-03-31 | $1.3M | 50k | 24.98 |
| 2020-12-31 | $38k | 1.4k | 26.67 |